Humira injection

Humira injection

C014/2357 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 53.5MB

Downloadable file size: 2.5MB

Price image Pricing

Please login to use the price calculator


Restrictions: Not to be shared on social media or embedded in a web page without permission.

Caption: Humira injection. Close-up of the mark left of a patient's skin after self-injecting a dose of the drug adalimumab, marketed under the name Humira. Adalimumab is a human monoclonal antibody that targets excess tumour necrosis factor (TNF) in the body, overproduction of which causes inflammation, swelling, and pain. It is used for the treatment of autoimmune diseases such as rheumatoid and psoriatic arthritis, Crohn's disease and ulcerative colitis.

Release details: Model release available. Property release not available.

Keywords: abdomen, abdominal, adalimumab, administering, anti tnf, anti-tnf, application, applying, arthritis, autoimmune disease, caucasian, close-up, crohn'ss disease, detail, diseases, drug, drugs, gastroenterological, gastroenterology, gi, healthcare, human, humira, ibd, injecting, injection, irritable bowel disease, male, man, mark, marked, medical, medication, medicine, patient, pen, people, person, pharmaceutic, pharmaceutical, pharmacological, pharmacology, pre-filled, prefilled, prescription drug, psoriatic, rheumatoid, rheumatological, rheumatology, self-administering, self-administration, self-injecting, syringe, treating, treatment, tumour necrosis factor, ulcerative colitis, white

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.